Fate determination in mesenchymal stem cells: A perspective from histone-modifying enzymes

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Huang, Biao ^a   Li, Gang ^b,c,d   Jiang, Xiao Hua ^a,c,d  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; ENZYME; ERG ASSOCIATED PROTEIN WITH A SET DOMAIN; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE GCN5; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 6; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; HISTONE MODIFYING ENZYME; LYSINE DEMETHYLASE 2A; LYSINE DEMETHYLASE 4B; LYSINE DEMETHYLASE 6A; LYSINE DEMETHYLASE 6B; LYSINE SPECIFIC DEMETHYLASE 1; MIXED LINEAGE LEUKEMIA PROTEIN 3; MIXED LINEAGE LEUKEMIA PROTEIN 4; PLANT HOMEODOMAIN FINGER 2; PROTEIN PR SET7; PROTEIN PR SET8; TAT INTERACTIVE PROTEIN 60; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ADIPOGENESIS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CHONDROGENESIS; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SPECIFICITY; EPIGENETICS; HEART DEVELOPMENT; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; MESENCHYMAL STEM CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; BIOLOGICAL THERAPY; CYTOLOGY; HISTONE CODE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROCEDURES; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE REGENERATION;

CELL DIFFERENTIATION; CELL LINEAGE; CELL- AND TISSUE-BASED THERAPY; GUIDED TISSUE REGENERATION; HISTONE CODE; HISTONES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TRANSCRIPTION FACTORS;

EID: 84928237252     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-015-0018-0     Document Type: Review

References (53)

1. Elgin SC. Heterochromatin and gene regulation in Drosophila. Curr Opin Genet Dev. 1996;6:193-202.
2. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41-5.
3. Greer EL, Shi Y. Histone methylation: A dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012;13:343-57.
4. Marmorstein R, Trievel RC. Histone modifying enzymes: structures, mechanisms, and specificities. Biochim Biophys Acta. 2009;1789:58-68.
5. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381-95.
6. Butler JS, Koutelou E, Schibler AC, Dent SY. Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease. Epigenomics. 2012;4:163-77.
7. Papp B, Plath K. Epigenetics of reprogramming to induced pluripotency. Cell. 2013;152:1324-43.
8. Marks H, Stunnenberg HG. Transcription regulation and chromatin structure in the pluripotent ground state. Biochim Biophys Acta. 1839;2014:129-37.
9. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R, et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell. 2010;7:249-57.
10. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125:315-26.
11. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell. 2009;4:80-93.
12. Liu L, Cheung TH, Charville GW, Hurgo BM, Leavitt T, Shih J, et al. Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep. 2013;4:189-204.
13. Hammoud SS, Nix DA, Zhang H, Purwar J, Carrell DT, Cairns BR. Distinctive chromatin in human sperm packages genes for embryo development. Nature. 2009;460:473-8.
14. Hassan MQ, Tare R, Lee SH, Mandeville M, Weiner B, Montecino M, et al. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol. 2007;27:3337-52.
15. Lawson KA, Teteak CJ, Gao J, Li N, Hacquebord J, Ghatan A, et al. ESET histone methyltransferase regulates osteoblastic differentiation of mesenchymal stem cells during postnatal bone development. FEBS Lett. 2013;587:3961-7.
16. Fritsch C, Brown JL, Kassis JA, Muller J. The DNA-binding polycomb group protein pleiohomeotic mediates silencing of a Drosophila homeotic gene. Development. 1999;126:3905-13.
17. Wei Y, Chen YH, Li LY, Lang J, Yeh SP, Shi B, et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol. 2011;13:87-94.
18. Musri MM, Carmona MC, Hanzu FA, Kaliman P, Gomis R, Parrizas M. Histone demethylase LSD1 regulates adipogenesis. J Biol Chem. 2010;285:30034-41.
19. Lee J, Saha PK, Yang QH, Lee S, Park JY, Suh Y, et al. Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc Natl Acad Sci U S A. 2008;105:19229-34.
20. Wakabayashi K, Okamura M, Tsutsumi S, Nishikawa NS, Tanaka T, Sakakibara I, et al. The peroxisome proliferator-Activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol. 2009;29:3544-55.
21. Okuno Y, Ohtake F, Igarashi K, Kanno J, Matsumoto T, Takada I, et al. Epigenetic regulation of adipogenesis by PHF2 histone demethylase. Diabetes. 2013;62:1426-34.
22. Ye L, Fan Z, Yu B, Chang J, Al Hezaimi K, Zhou X, et al. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell. 2012;11:50-61.
23. Hemming S, Cakouros D, Isenmann S, Cooper L, Menicanin D, Zannettino A, et al. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells. 2014;32:802-15.
24. Lee KH, Ju UI, Song JY, Chun YS. The histone demethylase PHF2 promotes fat cell differentiation as an epigenetic activator of both C/EBP alpha and C/EBP delta. Mol Cell. 2014. doi: 10.14348/molcells.2014.0180.
25. Tateishi K, Okada Y, Kallin EM, Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature. 2009;458:757-61.
26. Ng D, Thakker N, Corcoran CM, Donnai D, Perveen R, Schneider A, et al. Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat Genet. 2004;36:411-6.
27. Fan Z, Yamaza T, Lee JS, Yu J, Wang S, Fan G, et al. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol. 2009;11:1002-9.
28. Dong R, Yao R, Du J, Wang S, Fan Z. Depletion of histone demethylase KDM2A enhanced the adipogenic and chondrogenic differentiation potentials of stem cells from apical papilla. Exp Cell Res. 2013;319:2874-82.
29. Hata K, Takashima R, Amano K, Ono K, Nakanishi M, Yoshida M, et al. Arid5b facilitates chondrogenesis by recruiting the histone demethylase Phf2 to Sox9-regulated genes. Nat Commun. 2013;4:2850.
30. Shen J, Hovhannisyan H, Lian JB, Montecino MA, Stein GS, Stein JL, et al. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol Endocrinol. 2003;17:743-56.
31. Tan J, Lu J, Huang W, Dong Z, Kong C, Li L, et al. Genome-wide analysis of histone H3 lysine9 modifications in human mesenchymal stem cell osteogenic differentiation. PLoS One. 2009;4:e6792.
32. Furumatsu T, Tsuda M, Yoshida K, Taniguchi N, Ito T, Hashimoto M, et al. Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem. 2005;280:35203-8.
33. Furumatsu T, Asahara H. Histone acetylation influences the activity of Sox9-related transcriptional complex. Acta Med Okayama. 2010;64:351-7.
34. Gelman L, Zhou G, Fajas L, Raspe E, Fruchart JC, Auwerx J. p300 interacts with the N-And C-Terminal part of PPARgamma2 in a ligand-independent and-dependent manner, respectively. J Biol Chem. 1999;274:7681-8.
35. van Beekum O, Brenkman AB, Grontved L, Hamers N, van den Broek NJ, Berger R, et al. The adipogenic acetyltransferase Tip60 targets activation function 1 of peroxisome proliferator-Activated receptor gamma. Endocrinology. 2008;149:1840-9.
36. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006;4:263-73.
37. Haberland M, Carrer M, Mokalled MH, Montgomery RL, Olson EN. Redundant control of adipogenesis by histone deacetylases 1 and 2. J Biol Chem. 2010;285:14663-70.
38. Zhao QH, Wang SG, Liu SX, Li JP, Zhang YX, Sun ZY, et al. PPARgamma forms a bridge between DNA methylation and histone acetylation at the C/EBPalpha gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells. FEBS J. 2013;280:5801-14.
39. Huang S, Wang S, Bian C, Yang Z, Zhou H, Zeng Y, et al. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev. 2012;21:2531-40.
40. Aoyama T, Okamoto T, Fukiage K, Otsuka S, Furu M, Ito K, et al. Histone modifiers, YY1 and p300, regulate the expression of cartilage-specific gene, chondromodulin-I, in mesenchymal stem cells. J Biol Chem. 2010;285:29842-50.
41. Yu YL, Chou RH, Chen LT, Shyu WC, Hsieh SC, Wu CS, et al. EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling. J Biol Chem. 2011;286:9657-67.
42. Jeong SG, Ohn T, Kim SH, Cho GW. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells. Neurosci Lett. 2013;554:22-7.
43. Dong X, Pan R, Zhang H, Yang C, Shao J, Xiang L. Modification of histone acetylation facilitates hepatic differentiation of human bone marrow mesenchymal stem cells. PLoS One. 2013;8:e63405.
44. Li L, Zhu J, Tian J, Liu X, Feng C. A role for Gcn5 in cardiomyocyte differentiation of rat mesenchymal stem cells. Mol Cell Biochem. 2010;345:309-16.
45. Wang M, Yu Q, Wang L, Gu H. Distinct patterns of histone modifications at cardiac-specific gene promoters between cardiac stem cells and mesenchymal stem cells. Am J Physiol Cell Physiol. 2013;304:C1080-90.
46. Culmes M, Eckstein HH, Burgkart R, Nussler AK, Guenther M, Wagner E, et al. Endothelial differentiation of adipose-derived mesenchymal stem cells is improved by epigenetic modifying drug BIX-01294. Eur J Cell Biol. 2013;92:70-9.
47. Dekker FJ, Haisma HJ. Histone acetyl transferases as emerging drug targets. Drug Discov Today. 2009;14:942-8.
48. Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC. Epigenetic therapy of cancer with histone deacetylase inhibitors. J Cancer Res Ther. 2014;10:469-78.
49. Greiner D, Bonaldi T, Eskeland R, Roemer E, Imhof A. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol. 2005;1:143-5.
50. McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-Activating mutations. Nature. 2012;492:108-12.
51. Mikkelsen TS, Xu Z, Zhang X, Wang L, Gimble JM, Lander ES, et al. Comparative epigenomic analysis of murine and human adipogenesis. Cell. 2010;143:156-69.
52. Zhang Q, Ramlee MK, Brunmeir R, Villanueva CJ, Halperin D, Xu F. Dynamic and distinct histone modifications modulate the expression of key adipogenesis regulatory genes. Cell Cycle. 2012;11:4310-22.
53. Herlofsen SR, Bryne JC, Hoiby T, Wang L, Issner R, Zhang X, et al. Genome-wide map of quantified epigenetic changes during in vitro chondrogenic differentiation of primary human mesenchymal stem cells. BMC Genomics. 2013;14:105.